Drug company guilty-pays $1.4 billion

January 21, 2009
9:26 pm

Justice Seeker

Heather L. Ryan, R.N., C.L.N.C- Heather Ryan is a Certified Legal Nurse Consultant with 15 years of experience in the health care industry. Her expertise in reviewing medical records and assisting lawyers with the determination as to whether legal action should be taken provides an invaluable asset to the newsroom. Medical-malpractice, products liability, personal injury and workers’ compensation are some of the recent areas of litigation Ms. Ryan has focused her efforts on. A member of the Florida Justice Association, Heather maintains a long list of certifications and credentials to support her areas of expertise and stays up-to-date with her clinical knowledge working as an emergency room/trauma nurse, at a Level 1, Adult/Pediatric trauma and teaching institution in South Florida.

Drug company guilty-pays $1.4 billion

Eli Lilly agreed to pay $1.4 billion to settle violations of FDA laws. Drug company guilty of illegal marketing.West Palm Beach, FL (JusticeNewsFlash.com)–Eli Lilly has agreed to pay $1.4 billion in violation of regulations and guidelines in promoting Zyprexa as a treatment for dementia. As reported by MarketWatch, Eli Lilly & Co. has plead guilty to charges, by the U.S. Attorney in federal court in the Eastern District of Pennsylvania, for illegally marketing the medication. Lilly, has earned over $37 billion with Zyprexa, and is guilty of knowingly marketing the drug for the treatment of dementia, which has not been approved by the U.S. Food and Drug Administration (FDA). The Justice Department reached the agreed fine of $1.4 billion.Even though it is not illegal for doctors to prescribe drugs for treatment the FDA has not yet approved, it is illegal for drug companies to market medications for off-label use. Off-label is a term commonly used and defined by Wikipedia www.wikipedia.com as the practice by pharmaceutical companies in prescribing a medication for a purpose outside of the scope of a drug’s approved FDA label. The FDA considers these violations a serious crime.The settlement reached with the United States Justice Department has ordered Eli Lilly to comply with the inspector general’s office of the U.S. Department of Health and Human Services (HHS) http://www.hhs.gov/. To maintain compliance with HHS, an independent third party organization will review Eli Lilly’s policies, procedures, and practices and report back to the inspector general under their new corporate integrity agreement.JusticeNewsFlash.com news for South Florida personal injury lawyers